Stay updated on Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.

Latest updates to the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a deployed update to the page's version. This change is at the metadata level and does not alter the study details or user-facing content.SummaryDifference0.0%

- Check17 days agoChange DetectedTaoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the list of trial locations, updating the geographic sites where participants may enroll. This changes the geographic coverage of recruitment sites for the study.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s displayed software/UI revision tag has been updated from v3.5.2 to v3.5.3, indicating a site version change rather than an update to the clinical trial record.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision entry updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to the study details, layout, or navigation were observed.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed. This is a minor footer/metadata change with no effect on the study details presented.SummaryDifference0.0%

Stay in the know with updates to Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir Plus Ribavirin in Chronic HCV: Clinical Trial page.